|
| |

GE Healthcare Launches Facility Validation Services
Will enable more efficient compliance for
new or existing facilities
Piscataway, NJ, USA, May 11th, 2009 – GE Healthcare, a unit of General
Electric Company (NYSE: GE), announces the launch of GE Healthcare Facility
Validation Services, a new global service that will provide customers with more
efficient and comprehensive international regulatory compliance for their
facilities and manufacturing systems compared with complex traditional
approaches.
Applicable to any new or existing facility, GE Healthcare Facility Validation
Services uses a unique Modular Validation Platform to work with customers as
they plan and design their facilities and manufacturing processes to the
required regulatory standards. These new services leverage the latest regulatory
trends and guidances, along with unique processes and systems to provide an
improved regulatory compliance capability, with the potential to speed up
product time-to-market.
GE Healthcare Facility Validation Services will employ the Company’s extensive
project and business management expertise, as well as operational excellence
methodologies such as Lean and Six Sigma, to provide a world-class integrated
global service. Victor Bornsztejn, Global Growth Director, GE Healthcare,
states: “We aim to help eliminate the current disconnection between drug/process
development and facility validation. GE Healthcare has played a pivotal role in
biopharmaceutical drug and process development for decades, so we believe we are
uniquely positioned to drive this change in the industry.”
“The launch of GE Healthcare Facility Validation Services is a major milestone
for GE Healthcare, combining many of the Company’s capabilities,” adds Mr.
Bornsztejn. “Drug manufacturers are regularly receiving citations and warnings
that are linked to their validation, usually for reasons that are easily
avoidable. We believe our range of solutions and expertise enables us to offer a
very broad range of complete product/lifecycle services at a time when
compliance and cost-containment are key industry concerns.”
For more information please visit:
www.gelifesciences.com/validation
-ENDS-
About GE Healthcare
GE Healthcare provides transformational medical technologies and services
that are shaping a new age of patient care. Our broad expertise in medical
imaging and information technologies, medical diagnostics, patient monitoring
systems, drug discovery, biopharmaceutical manufacturing technologies,
performance improvement and performance solutions services help our customers to
deliver better care to more people around the world at a lower cost. In
addition, we partner with healthcare leaders, striving to leverage the global
policy change necessary to implement a successful shift to sustainable
healthcare systems.
Our "healthymagination" vision for the future invites the world to join us on
our journey as we continuously develop innovations focused on reducing costs,
increasing access and improving quality and efficiency around the world.
Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of
General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than
46,000 people committed to serving healthcare professionals and their patients
in more than 100 countries. For more information about GE Healthcare, visit our
website at www.gehealthcare.com
Contact
GE Healthcare
Victor Bornsztejn
Global Growth Director, Life Sciences Service
+1 732 457 8056
Victor.Bornsztejn@ge.com
College Hill
Lynne Trowbridge, Gurminder Marwaha, Jo Bowler
+44 (0)1260 296 500
ge-validation@collegehill.com
| |
|